Kuros Biosciences AG
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CSBTF | SIBN | 1789.HK | OFIX | BVS | XTNT | |
|---|---|---|---|---|---|---|
| Market cap | 914.40M | 1.13B | 4.88B | 364.60M | 759.38M | 43.04M |
| P/E (TTM) | 104.5 | — | 12.2 | — | 13.7 | — |
| Forward P/E | — | -80.5 | 9.4 | 24.4 | 12.2 | -10.2 |
| Price/book | 10.3 | 6.1 | 1.6 | 0.9 | 3.2 | 1.1 |
| Dividend yield | — | — | 2.62% | — | — | — |
| 1-year change | −31.03% | +64.25% | −21.60% | −33.79% | +52.67% | −62.03% |
| Today | 0.00% | +4.96% | +2.67% | −7.20% | −2.89% | +3.65% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All CSBTF news ›Kuros Biosciences increases 2026 annual guidance, The company reports 40% year-over-year increase in sales in the first nine months of 2026
Ad hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences increases 2026 annual guidance The company reports 40% year-over-year increase in sales in the first nine months of 2026 Schlieren (Zurich), Switzerland,…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- mykxlg.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.